List of Tables
Table 1. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunoglobulin
Table 3. Key Players of Fibrinogen
Table 4. Key Players of Serum Albumin
Table 5. Key Players of Fetal Bovine Serum
Table 6. Key Players of Thrombin
Table 7. Key Players of New Born Calf Serum
Table 8. Global Animal Blood Plasma and Derivatives Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Animal Blood Plasma and Derivatives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Animal Blood Plasma and Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Animal Blood Plasma and Derivatives Market Share by Region (2020-2025)
Table 12. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Animal Blood Plasma and Derivatives Market Share by Region (2026-2031)
Table 14. Animal Blood Plasma and Derivatives Market Trends
Table 15. Animal Blood Plasma and Derivatives Market Drivers
Table 16. Animal Blood Plasma and Derivatives Market Challenges
Table 17. Animal Blood Plasma and Derivatives Market Restraints
Table 18. Global Animal Blood Plasma and Derivatives Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Animal Blood Plasma and Derivatives Market Share by Players (2020-2025)
Table 20. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2024)
Table 21. Ranking of Global Top Animal Blood Plasma and Derivatives Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Animal Blood Plasma and Derivatives Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Animal Blood Plasma and Derivatives, Headquarters and Area Served
Table 24. Global Key Players of Animal Blood Plasma and Derivatives, Product and Application
Table 25. Global Key Players of Animal Blood Plasma and Derivatives, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Animal Blood Plasma and Derivatives Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2020-2025)
Table 29. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2026-2031)
Table 31. Global Animal Blood Plasma and Derivatives Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2020-2025)
Table 33. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2026-2031)
Table 35. North America Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Animal Blood Plasma and Derivatives Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 50. Proliant Inc. Company Details
Table 51. Proliant Inc. Business Overview
Table 52. Proliant Inc. Animal Blood Plasma and Derivatives Product
Table 53. Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 54. Proliant Inc. Recent Development
Table 55. Thermo Fisher Scientific, Inc. Company Details
Table 56. Thermo Fisher Scientific, Inc. Business Overview
Table 57. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product
Table 58. Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 59. Thermo Fisher Scientific, Inc. Recent Development
Table 60. Merck KGaA Company Details
Table 61. Merck KGaA Business Overview
Table 62. Merck KGaA Animal Blood Plasma and Derivatives Product
Table 63. Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 64. Merck KGaA Recent Development
Table 65. Kraeber & Co GmbH Company Details
Table 66. Kraeber & Co GmbH Business Overview
Table 67. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product
Table 68. Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 69. Kraeber & Co GmbH Recent Development
Table 70. LAMPIRE Biological Laboratories, Inc. Company Details
Table 71. LAMPIRE Biological Laboratories, Inc. Business Overview
Table 72. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product
Table 73. LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 74. LAMPIRE Biological Laboratories, Inc. Recent Development
Table 75. Lake Immunogenics, Inc. Company Details
Table 76. Lake Immunogenics, Inc. Business Overview
Table 77. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product
Table 78. Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 79. Lake Immunogenics, Inc. Recent Development
Table 80. Rocky Mountain Biologicals Inc. Company Details
Table 81. Rocky Mountain Biologicals Inc. Business Overview
Table 82. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product
Table 83. Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 84. Rocky Mountain Biologicals Inc. Recent Development
Table 85. ANZCO Foods Ltd. Company Details
Table 86. ANZCO Foods Ltd. Business Overview
Table 87. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product
Table 88. ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 89. ANZCO Foods Ltd. Recent Development
Table 90. Auckland BioSciences Ltd. Company Details
Table 91. Auckland BioSciences Ltd. Business Overview
Table 92. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product
Table 93. Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 94. Auckland BioSciences Ltd. Recent Development
Table 95. Bovogen Biologicals Pty Ltd. Company Details
Table 96. Bovogen Biologicals Pty Ltd. Business Overview
Table 97. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product
Table 98. Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 99. Bovogen Biologicals Pty Ltd. Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Animal Blood Plasma and Derivatives Picture
Figure 2. Global Animal Blood Plasma and Derivatives Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Animal Blood Plasma and Derivatives Market Share by Type: 2024 VS 2031
Figure 4. Immunoglobulin Features
Figure 5. Fibrinogen Features
Figure 6. Serum Albumin Features
Figure 7. Fetal Bovine Serum Features
Figure 8. Thrombin Features
Figure 9. New Born Calf Serum Features
Figure 10. Global Animal Blood Plasma and Derivatives Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Animal Blood Plasma and Derivatives Market Share by Application: 2024 VS 2031
Figure 12. Food & Beverages Case Studies
Figure 13. Pharmaceuticals Case Studies
Figure 14. Cosmetics Case Studies
Figure 15. Feed Case Studies
Figure 16. Others Case Studies
Figure 17. Animal Blood Plasma and Derivatives Report Years Considered
Figure 18. Global Animal Blood Plasma and Derivatives Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Animal Blood Plasma and Derivatives Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Animal Blood Plasma and Derivatives Market Share by Region: 2024 VS 2031
Figure 21. Global Animal Blood Plasma and Derivatives Market Share by Players in 2024
Figure 22. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2024
Figure 24. North America Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 26. United States Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 30. Germany Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Animal Blood Plasma and Derivatives Market Share by Region (2020-2031)
Figure 38. China Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 46. Mexico Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 50. Turkey Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Proliant Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 54. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 55. Merck KGaA Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 56. Kraeber & Co GmbH Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 57. LAMPIRE Biological Laboratories, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 58. Lake Immunogenics, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 59. Rocky Mountain Biologicals Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 60. ANZCO Foods Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 61. Auckland BioSciences Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 62. Bovogen Biologicals Pty Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed